Jeffrey Rothman, MD | |
1460 Victory Blvd, Staten Island, NY 10301-3914 | |
(718) 442-0300 | |
Not Available |
Full Name | Jeffrey Rothman |
---|---|
Gender | Male |
Speciality | Endocrinology |
Experience | 54 Years |
Location | 1460 Victory Blvd, Staten Island, New York |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1811982812 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 129881 (New York) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Staten Island University Hospital | Staten island, NY | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Physicians Group Endocrinology Pllc | 4688913155 | 4 |
News Archive
Over the last three years, the Opera range of care beds and pressure care mattresses has evolved to become a core product range for our two key marketplaces; Care Homes, and Care at Home.
A new study suggests that bright light at the end of a night shift may have potential as a countermeasure to improve driving performance, particularly for low light work environments and commutes that occur before dawn.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
ITL Group's global operation will be front and centre at the 69th Annual Scientific Meeting and Clinical Lab, from 29 July to 3 August in San Diego, California, marking its first appearance in 15 years.
› Verified 4 days ago
Entity Name | University Physicians Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104872134 PECOS PAC ID: 0547157356 Enrollment ID: O20040304000265 |
News Archive
Over the last three years, the Opera range of care beds and pressure care mattresses has evolved to become a core product range for our two key marketplaces; Care Homes, and Care at Home.
A new study suggests that bright light at the end of a night shift may have potential as a countermeasure to improve driving performance, particularly for low light work environments and commutes that occur before dawn.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
ITL Group's global operation will be front and centre at the 69th Annual Scientific Meeting and Clinical Lab, from 29 July to 3 August in San Diego, California, marking its first appearance in 15 years.
› Verified 4 days ago
Entity Name | University Physicians Group Endocrinology Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1366906588 PECOS PAC ID: 4688913155 Enrollment ID: O20190227001678 |
News Archive
Over the last three years, the Opera range of care beds and pressure care mattresses has evolved to become a core product range for our two key marketplaces; Care Homes, and Care at Home.
A new study suggests that bright light at the end of a night shift may have potential as a countermeasure to improve driving performance, particularly for low light work environments and commutes that occur before dawn.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
ITL Group's global operation will be front and centre at the 69th Annual Scientific Meeting and Clinical Lab, from 29 July to 3 August in San Diego, California, marking its first appearance in 15 years.
› Verified 4 days ago
Mailing Address | Practice Location Address |
---|---|
Jeffrey Rothman, MD 1460 Victory Blvd, Staten Island, NY 10301-3914 Ph: (718) 442-0300 | Jeffrey Rothman, MD 1460 Victory Blvd, Staten Island, NY 10301-3914 Ph: (718) 442-0300 |
News Archive
Over the last three years, the Opera range of care beds and pressure care mattresses has evolved to become a core product range for our two key marketplaces; Care Homes, and Care at Home.
A new study suggests that bright light at the end of a night shift may have potential as a countermeasure to improve driving performance, particularly for low light work environments and commutes that occur before dawn.
Using wireless technology may speed patients' postoperative recovery following heart surgery and improve post-discharge outcomes, according to a study in the September 2013 issue of The Annals of Thoracic Surgery.
Perrigo Company announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application (ANDA) for azelastine hydrochloride nasal spray (0.15%) and has notified Meda Pharmaceuticals, Inc., the owner of the New Drug Application (NDA) of its filing. The ANDA filing involved contributions from both Perrigo and Impax Laboratories, Inc., who will share costs and benefits of this project.
ITL Group's global operation will be front and centre at the 69th Annual Scientific Meeting and Clinical Lab, from 29 July to 3 August in San Diego, California, marking its first appearance in 15 years.
› Verified 4 days ago
Liliane Sarkis Deeb, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 4106 Hylan Blvd, Staten Island, NY 10308 Phone: 718-226-7855 Fax: 718-227-5814 | |
Deepak Vadada, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1050 Clove Rd, Staten Island, NY 10301 Phone: 718-816-6440 Fax: 718-816-3611 | |
Dr. Samantha Maria Lee, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-9510 Fax: 718-226-3473 | |
Dr. Jean Chalhoub, M.D Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 475 Seaview Avenue, Department Of Internal Medicine, Staten Island, NY 10305 Phone: 718-226-8855 | |
Dr. Gustave Stephen Drivas, M.D., Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 5405 Hylan Blvd, Staten Island, NY 10312 Phone: 718-948-3890 Fax: 718-948-3961 | |
Dr. Beatrice Nogueira, MD Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 475 Seaview Ave, Staten Island, NY 10305 Phone: 718-226-6902 Fax: 718-226-6844 | |
Dr. Felicia Tenedios, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1200 South Ave Ste 204, Staten Island, NY 10314 Phone: 718-447-0055 Fax: 718-876-5212 |